HOME >> MEDICINE >> NEWS
M. D. Anderson reports first drug activity in T315I-Positive CML, ALL and JAK-2-Positive MPD

ORLANDO -- Researchers at The University of Texas M. D. Anderson Cancer Center reported today that MK-0457 (VX-680), a novel multi-kinase inhibitor, is clinically active against multiple target mutations in two types of leukemia and myeloproliferative disorders, and produces few side effects for patients.

Francis J. Giles, M.D., professor in the Department of Leukemia at M. D. Anderson Cancer Center, presented the Phase I / II trial data today at the annual meeting of the American Society of Hematology.

According to Giles, the study of 44 patients, conducted at M. D. Anderson Cancer Center and Duke University Medical Center, showed the first clinical activity of a kinase inhibitor against the T315I BCR-ABL mutation found in chronic myeloid leukemia (CML) and acute lymphocytic leukemia (ALL). In addition, the trial showed the first activity against the JAK-2 mutation found in myeloproliferative disorders (MPD), a group of blood diseases that can evolve into leukemia. MK-0457 has also been found in previous studies to inhibit Aurora kinases A, B, C and FLT3 in leukemias.

Giles reported that patients on the study experienced minimal side effects, such that no maximum tolerated dose was defined. Mild side effects included lowering of white blood cells, hair loss, nausea and inflammation of the mouth.

"MK-0457 is a drug that produces clinical and biologic activity where we have not seen it before - in T315I-positive CML and ALL and JAK-2-positive MPD. This is a very active biologic agent for patients with advanced leukemia, and has very few side effects, all of which are quite manageable," Giles said. "With the data from this trial, we have a strong rationale to take this agent forward to more definitive and larger studies."

Though CML, ALL and MPD are relatively rare cancers, they are very aggressive and often fatal after failing standard therapy, said Giles. For the subset of leukemia patients who have the T315I
'"/>

Contact: Laura Sussman
lsussman@mdanderson.org
832-264-8893
University of Texas M. D. Anderson Cancer Center
11-Dec-2006


Page: 1 2 3

Related medicine news :

1. M.D. Anderson collaborates with Federal Ministry of Health in Nigeria
2. M. D. Anderson, BCM, launch research effort targeting asthma and allergic diseases
3. M. D. Anderson teaches the art of aromatherapy to soothe and heal
4. M. D. Anderson: Setting the benchmark in brain tumor treatment
5. International award honors M. D. Anderson President for pioneering research
6. Rice, M. D. Anderson win funds for bench to bed training
7. Newest M.D. Anderson SPORE to fund breast cancer research
8. AstraZeneca and M. D. Anderson Cancer Center form umbrella scientific collaboration agreements
9. Red and Charline McCombs contribute $30 million to M. D. Anderson research effort
10. M. D. Anderson announces collaboration with Indias largest yoga research institution
11. New study reports hotel guests at risk from carbon monoxide poisoning

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/19/2019)... ... 19, 2019 , ... Marking a key milestone in the ... on Wednesday will lift into place the final steel beam at AHN ... year. , The nearly 79,000-square-foot facility – located at 6321 Route 30, Greensburg, ...
(Date:2/19/2019)... HILLS, Calif. (PRWEB) , ... February 19, 2019 ... ... Wachler Vision Institute, Brian Boxer Wachler, MD, has launched the first ever supplement ... that can lead to severe to severe vision loss. The supplement, KC Defense, ...
(Date:2/19/2019)... ... February 19, 2019 , ... ... with town halls across the country , A partnership between Liberty University and ... crisis, continues with its next town hall event on Tuesday, February 19, at ...
(Date:2/19/2019)... JACKSONVILLE, Fla. (PRWEB) , ... February 19, 2019 ... ... professors say yes! , “Nova Filtration is based in The Villages FL proudly ... success in our new franchised Territory in the greater Jacksonville area selling and ...
(Date:2/19/2019)... ... February 19, 2019 , ... Dr. Lombardi is ... Oncology Institute of Hope and Innovation. , Dr. Lombardi completed his undergraduate in ... received his medical degree from the University of Rochester School of Medicine. He ...
Breaking Medicine News(10 mins):
(Date:2/16/2019)... ... February 15, 2019 , ... ... Allison Marlow of Perio-Implant Care are urging patients to take their oral health ... cancers, diabetes, Alzheimer's and dementia, and risk of pre-term birth, there is plenty ...
(Date:2/16/2019)... ... 15, 2019 , ... Dr. Lucas Bryant, board-certified Face expert ... Haute Beauty Network, well known for their exclusivity, and luxurious lifestyle, is privileged ... newest addition to the Haute Living partnership. , Haute Beauty offers a prominent ...
(Date:2/14/2019)... Colo. (PRWEB) , ... February 14, 2019 , ... ... Month , Lewis and Clark College Emeritus Professor of Education Gregory A. Smith ... They discuss the emergence of Brand Ambassador programs, a new phenomenon in the ...
Breaking Medicine Technology:
Cached News: